1. Expression Profile of microRNAs in Hypertrophic Cardiomyopathy and Effects of microRNA-20 in Inducing Cardiomyocyte Hypertrophy Through Regulating GeneMFN2
   Dongdong Sun et al, 2019, DNA and Cell Biology CrossRef
2. CaMK II in Cardiovascular Diseases, Especially CaMK II-δ: Friends or Enemies
   Yu-Qing Tan et al, 2024, Drug Design, Development and Therapy CrossRef
3. Myostatin promotes proliferation of bovine muscle satellite cells through activating TRPC4/Ca2+/Calcineurin/NFATc3 pathway
   Yajie Gao et al, 2024, Journal of Integrative Agriculture CrossRef
4. Activation of CaMKII/HDAC4 by SDF1 contributes to pulmonary arterial hypertension via stabilization Runx2
   Yuqian Chen et al, 2024, European Journal of Pharmacology CrossRef
5. Effect of atorvastatin on cardiomyocyte hypertrophy through suppressing MURC induced by volume overload and cyclic stretch
   Wen‐Pin Cheng et al, 2019, Journal of Cellular and Molecular Medicine CrossRef
6. Distinct roles of calmodulin and Ca2+/calmodulin-dependent protein kinase II in isopreterenol-induced cardiac hypertrophy
   Siqi Wang et al, 2020, Biochemical and Biophysical Research Communications CrossRef
7. Small Molecule Compound Nerolidol attenuates Hypertension induced hypertrophy in spontaneously hypertensive rats through modulation of Mel-18-IGF-IIR signalling
   Yueh-Min Lin et al, 2021, Phytomedicine CrossRef
8. Leu27IGF‐II‐induced hypertrophy in H9c2 cardiomyoblasts is ameliorated by saffron by regulation of calcineurin/NFAT and CaMKIIδ signaling
   Chin‐Yi Lin et al, 2021, Environmental Toxicology CrossRef